VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

EBMT 2020 | Latest news in cellular therapies

Christian Chabannon, MD, PhD, Aix Marseille Université (AMU) School of Medicine, Marseille, France, talks on some of the exciting innovative cellular therapies in development including Zynteglo, a gene-therapy approved in Europe for the treatment of beta thalassemia. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).

Disclosures

Sanofi SA, Kite / Gilead, Novartis, Celgene / BMS, Janssen, Bellicum Pharmaceuticals, Terumo BCT: speakers bureau & advisory boards

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter